1. Home
  2. TBI vs TTRX Comparison

TBI vs TTRX Comparison

Compare TBI & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrueBlue Inc.

TBI

TrueBlue Inc.

N/A

Current Price

$3.94

Market Cap

129.9M

ML Signal

N/A

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$3.45

Market Cap

116.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TBI
TTRX
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.9M
116.0M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
TBI
TTRX
Price
$3.94
$3.45
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$8.00
AVG Volume (30 Days)
264.0K
13.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
61.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.25
N/A
Revenue Next Year
$3.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.44
$2.57
52 Week High
$7.78
$5.98

Technical Indicators

Market Signals
Indicator
TBI
TTRX
Relative Strength Index (RSI) 39.93 45.53
Support Level $3.44 $2.64
Resistance Level $6.28 $4.01
Average True Range (ATR) 0.27 0.20
MACD 0.02 0.02
Stochastic Oscillator 52.19 35.90

Price Performance

Historical Comparison
TBI
TTRX

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

Share on Social Networks: